SEC Filing Details
SEC Filing Details
Document Details
Form
Filing Date
Dec 20, 2013
Document Date
Dec 20, 2013
Form Description
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Filing Group
Registration Statements
Company
Akebia Therapeutics
Issuer
Akebia Therapeutics, Inc.
Print Page
Email Page
Contact IR
Email Alerts
Tear Sheet
Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142
+1 617.871.2098 phone
+1 617.871.2099 fax